Bank of America
ROIV icon

Bank of America’s Roivant Sciences ROIV Stock Holding History

Bank of America’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154M Buy
4,341,381
+1,177,560
+37% +$34.8M 0.01% 919
2026
Q1 		$87.6M Buy
3,163,821
+235,493
+8% +$6.05M 0.01% 1205
2025
Q4 		$63.5M Buy
2,928,328
+240,523
+9% +$4.75M ﹤0.01% 1387
2025
Q3 		$40.7M Buy
2,687,805
+35,762
+1% +$443K ﹤0.01% 1924
2025
Q2 		$29.9M Buy
2,652,043
+331,829
+14% +$3.6M ﹤0.01% 2153
2025
Q1 		$23.4M Buy
2,320,214
+601,945
+35% +$6.51M ﹤0.01% 2278
2024
Q4 		$20.3M Sell
1,718,269
-415,363
-19% -$4.91M ﹤0.01% 2289
2024
Q3 		$24.6M Sell
2,133,632
-510,085
-19% -$5.81M ﹤0.01% 2198
2024
Q2 		$27.9M Buy
2,643,717
+393,540
+17% +$4.31M ﹤0.01% 1931
2024
Q1 		$23.7M Buy
2,250,177
+1,488,805
+196% +$16.1M ﹤0.01% 2109
2023
Q4 		$8.55M Sell
761,372
-353,521
-32% -$3.45M ﹤0.01% 3053
2023
Q3 		$13M Buy
1,114,893
+87,009
+8% +$984K ﹤0.01% 2468
2023
Q2 		$10.4M Sell
1,027,884
-1,273
-0.1% -$11.4K ﹤0.01% 2669
2023
Q1 		$7.6M Buy
1,029,157
+815,443
+382% +$6.71M ﹤0.01% 3100
2022
Q4 		$1.71M Buy
213,714
+181,393
+561% +$1.01M ﹤0.01% 4396
2022
Q3 		$104K Buy
32,321
+11,742
+57% +$45.5K ﹤0.01% 6331
2022
Q2 		$84K Sell
20,579
-60,139
-75% -$239K ﹤0.01% 6565
2022
Q1 		$399K Buy
+80,718
New +$532K ﹤0.01% 5990

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bank of America's ROIV Position: Q2 2026 in Review

Bank of America increased its Roivant Sciences (ROIV) stake by 37% in Q2 2026, buying an estimated $34.8M and bringing the position to 4,341,381 shares worth $154M. The position accounts for 0.01% of the portfolio, ranked #919.

Bank of America first reported a position in ROIV in Q1 2022 and has held it in 18 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Bank of America held 4,341,381 shares of Roivant Sciences worth $154M as of Q2 2026.
  • Bank of America bought 1,177,560 Roivant Sciences shares in Q2 2026, an estimated $34.8M.
  • Roivant Sciences made up 0.01% of Bank of America's portfolio in Q2 2026, its #919 holding.
  • Bank of America first reported a position in Roivant Sciences in Q1 2022 and has held it in 18 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.